Autologous serum eye drops diluted with sodium hyaluronate: clinical and experimental comparative study
Authors:
- José S. López‐GarcíaJLJosé S. López‐García
- Isabel García‐LozanoIGIsabel García‐Lozano
- Luis RivasLRLuis Rivas
- Nuria RamírezNRNuria Ramírez
- Rafaela RaposoRRRafaela Raposo
- Maria T. MéndezMMMaria T. Méndez
- Maria T MéndezMMMaria T Méndez
- 26 July 2013
- journal article
- research article
- Published by Wiley in Acta Ophthalmologica
- Vol. 92 (1) , e22-e29
Abstract
: Purpose: To assess the efficacy of sodium hyaluronate as vehicle for diluting autologous serum.Methods: The concentration and temporal stability of EGF, TGF‐β, PDGF‐AB and albumin in fresh and frozen samples of autologous serum diluted with sodium hyaluronate and saline solution, as well as the pH, osmolarity and density was studied. In parallel, the clinic effects of autologous serum diluted to 20% with sodium hyaluronate were compared with another solution of autologous serum diluted to 20% with saline in a prospective, comparative, randomized and double‐blind study in 26 patients (52 eyes) with Sjögren syndrome. Patients underwent a complete ophthalmic assessment including tear film evaluation and corneal and conjunctival impression cytology at the beginning of the study and 2 months later.Results: The growth factor (GF) concentration remained stable during 1 month at 4°C both in fresh and defrosted samples without any differences being found between both preparations. No differences were found related to osmolarity, pH and density between these preparations before and after frosting. Autologous serum diluted with sodium hyaluronate caused a significant improvement of the tear film stability, fluorescein and rose Bengal stain, break‐up time, corneal and conjunctival squamous metaplasia as well as in the patient subjective perception.Conclusions: Sodium hyaluronate is an excellent vehicle for diluting autologous serum due to the gradual release of GF and increasing their duration and effect on the ocular surface. Preparations diluted with sodium hyaluronate are better tolerated by patients and require a lower number of drops administrations.Keywords
This publication has 25 references indexed in Scilit:
- New formulation of vasoactive intestinal peptide using liposomes in hyaluronic acid gel for uveitisJournal of Controlled Release, 2009
- Autologous Serum Eyedrops in the Treatment of Aniridic KeratopathyOphthalmology, 2008
- Fluorophotometric measurement of the precorneal residence time of topically applied hyaluronic acidBritish Journal of Ophthalmology, 2007
- Low molecular weight hyaluronan shielding of DNA/PEI polyplexes facilitates CD44 receptor mediated uptake in human corneal epithelial cellsThe Journal of Gene Medicine, 2007
- Estudio comparativo entre el hialuronato sódico al 0,15% y el alcohol poliviníco como tratamiento para el ojo secoArchivos de la Sociedad Española de Oftalmología, 2005
- Hyaluronic Acid in the Treatment and Prevention of Skin Diseases: Molecular Biological, Pharmaceutical and Clinical AspectsSkin Pharmacology and Physiology, 2004
- Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitroBritish Journal of Ophthalmology, 2004
- Enhancement of the Mydriatic Response to Tropicamide by Bioadhesive PolymersJournal of Ocular Pharmacology and Therapeutics, 2000
- Topographical distribution of ocular surface cells by the use of impression cytologyActa Ophthalmologica, 1991
- The Effect of Sodium Hyaluronate on the Migration of Rabbit Corneal Epithelium. I. An In Vitro StudyJournal of Ocular Pharmacology and Therapeutics, 1990